Anti-CTLA-4 (CD 152) monoclonal antibody-induced autoimmune interstitial nephritis

Targeted immune-modulating agents are entering clinical practice in many specialties, providing novel therapeutic possibilities but introducing new potential toxicities. We present the first reported case, to our knowledge, of immune-mediated nephritis following the administration of Tremelimumab (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Jolly, Elaine C., Clatworthy, Menna R., Lawrence, Christopher, Nathan, Paul D., Farrington, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421243/
https://www.ncbi.nlm.nih.gov/pubmed/25984021
http://dx.doi.org/10.1093/ndtplus/sfp048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421243/
https://www.ncbi.nlm.nih.gov/pubmed/25984021
http://dx.doi.org/10.1093/ndtplus/sfp048

Ejemplares similares